78 related articles for article (PubMed ID: 7757808)
1. Biochemical characterization of Tau proteins during cerebral aging of the lemurian primate Microcebus murinus.
Delacourte A; Sautière PE; Wattez A; Mourton-Gilles C; Petter A; Bons N
C R Acad Sci III; 1995 Jan; 318(1):85-9. PubMed ID: 7757808
[TBL] [Abstract][Full Text] [Related]
2. Immunocytochemical characterization of Tau proteins during cerebral aging of the lemurian primate Microcebus murinus.
Bons N; Jallageas V; Silhol S; Mestre-Frances N; Petter A; Delacourte A
C R Acad Sci III; 1995 Jul; 318(7):741-7. PubMed ID: 7583762
[TBL] [Abstract][Full Text] [Related]
3. Immunocytochemical characterization of Tau proteins during cerebral aging of the lemurian primate Microcebus murinus.
Bons N; Jallageas V; Silhol S; Mestre-Frances N; Petter A; Delacourte A
C R Acad Sci III; 1995 Jan; 318(1):77-83. PubMed ID: 7757807
[TBL] [Abstract][Full Text] [Related]
4. Microcebus murinus: a useful primate model for human cerebral aging and Alzheimer's disease?
Bons N; Rieger F; Prudhomme D; Fisher A; Krause KH
Genes Brain Behav; 2006 Mar; 5(2):120-30. PubMed ID: 16507003
[TBL] [Abstract][Full Text] [Related]
5. Cloning of the presenilin 2 cDNA and its distribution in brain of the primate, Microcebus murinus: coexpression with betaAPP and Tau proteins.
Calenda A; Mestre-Francés N; Czech C; Pradier L; Petter A; Perret M; Bons N; Bellis M
Neurobiol Dis; 1998 Nov; 5(5):323-33. PubMed ID: 10069575
[TBL] [Abstract][Full Text] [Related]
6. [Similarities between cerebral amyloid plaques in aged lemurian and in human with Alzheimer's disease].
Bons N; Mestre N
C R Seances Soc Biol Fil; 1993; 187(4):516-25. PubMed ID: 8019922
[TBL] [Abstract][Full Text] [Related]
7. Identification of a unique apolipoprotein E allele in Microcebus murinus; ApoE brain distribution and co-localization with beta-amyloid and tau proteins.
Calenda A; Jallageas V; Silhol S; Bellis M; Bons N
Neurobiol Dis; 1995 Jun; 2(3):169-76. PubMed ID: 9174000
[TBL] [Abstract][Full Text] [Related]
8. Constitutive Dyrk1A is abnormally expressed in Alzheimer disease, Down syndrome, Pick disease, and related transgenic models.
Ferrer I; Barrachina M; Puig B; Martínez de Lagrán M; Martí E; Avila J; Dierssen M
Neurobiol Dis; 2005 Nov; 20(2):392-400. PubMed ID: 16242644
[TBL] [Abstract][Full Text] [Related]
9. Distribution of lithostathine in the mouse lemur brain with aging and Alzheimer's-like pathology.
Marchal S; Givalois L; Verdier JM; Mestre-Francés N
Neurobiol Aging; 2012 Feb; 33(2):431.e15-25. PubMed ID: 21371784
[TBL] [Abstract][Full Text] [Related]
10. Spatial and temporal distribution of intracellular free cholesterol in brains of a Niemann-Pick type C mouse model showing hyperphosphorylated tau protein. Implications for Alzheimer's disease.
Treiber-Held S; Distl R; Meske V; Albert F; Ohm TG
J Pathol; 2003 May; 200(1):95-103. PubMed ID: 12692847
[TBL] [Abstract][Full Text] [Related]
11. Quantitative analysis of tau protein-immunoreactive accumulations and beta amyloid protein deposits in the cerebral cortex of the mouse lemur, Microcebus murinus.
Giannakopoulos P; Silhol S; Jallageas V; Mallet J; Bons N; Bouras C; Delaère P
Acta Neuropathol; 1997 Aug; 94(2):131-9. PubMed ID: 9255387
[TBL] [Abstract][Full Text] [Related]
12. Unique Alzheimer's disease paired helical filament specific epitopes involve double phosphorylation at specific sites.
Hoffmann R; Lee VM; Leight S; Varga I; Otvos L
Biochemistry; 1997 Jul; 36(26):8114-24. PubMed ID: 9201960
[TBL] [Abstract][Full Text] [Related]
13. Truncated tau at D421 is associated with neurodegeneration and tangle formation in the brain of Alzheimer transgenic models.
Zhang Q; Zhang X; Sun A
Acta Neuropathol; 2009 Jun; 117(6):687-97. PubMed ID: 19190923
[TBL] [Abstract][Full Text] [Related]
14. Tauopathy in human and experimental variant Creutzfeldt-Jakob disease.
Giaccone G; Mangieri M; Capobianco R; Limido L; Hauw JJ; Haïk S; Fociani P; Bugiani O; Tagliavini F
Neurobiol Aging; 2008 Dec; 29(12):1864-73. PubMed ID: 17560687
[TBL] [Abstract][Full Text] [Related]
15. Neighbored phosphorylation sites as PHF-tau specific markers in Alzheimer's disease.
Singer D; Lehmann J; Hanisch K; Härtig W; Hoffmann R
Biochem Biophys Res Commun; 2006 Aug; 346(3):819-28. PubMed ID: 16781671
[TBL] [Abstract][Full Text] [Related]
16. Low molecular weight species of tau in Alzheimer's disease are dependent on tau phosphorylation sites but not on delayed post-mortem delay in tissue processing.
Santpere G; Puig B; Ferrer I
Neurosci Lett; 2006 May; 399(1-2):106-10. PubMed ID: 16488541
[TBL] [Abstract][Full Text] [Related]
17. Beta-amyloid deposition and tau phosphorylation in clinically characterized aged cats.
Head E; Moffat K; Das P; Sarsoza F; Poon WW; Landsberg G; Cotman CW; Murphy MP
Neurobiol Aging; 2005 May; 26(5):749-63. PubMed ID: 15708450
[TBL] [Abstract][Full Text] [Related]
18. Effect of cortistatin on tau phosphorylation at Ser262 site.
Rubio A; Pérez M; de Lecea L; Avila J
J Neurosci Res; 2008 Aug; 86(11):2462-75. PubMed ID: 18438934
[TBL] [Abstract][Full Text] [Related]
19. beta-Amyloid protein precursor in Microcebus murinus: genotyping and brain localization.
Silhol S; Calenda A; Jallageas V; Mestre-Frances N; Bellis M; Bons N
Neurobiol Dis; 1996; 3(3):169-82. PubMed ID: 8980017
[TBL] [Abstract][Full Text] [Related]
20. Microglial tau undergoes phosphorylation-independent modification after ischemia.
Uchihara T; Nakamura A; Arai T; Ikeda K; Tsuchiya K
Glia; 2004 Jan; 45(2):180-7. PubMed ID: 14730711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
